Larimar Therapeutics Inc. Skyrocketed
Wed, Jan 26, 2022 at 05:30 PM
Larimar Therapeutics Inc. (LRMR:NASDAQ) shot up at $10.5, representing a gain of 21.2%. On Tue, Jan 25, 2022, LRMR:NASDAQ hit a New 2-Week Intraday Low of $8.55. The stock got featured on our News Catalysts scanner on Wed, Jan 19, 2022 at 09:00 AM in the 'MISCELLANEOUS' category. From Wed, Jan 12, 2022, the stock recorded 50.00% Up Days and 22.22% Green Days
The share price of the company has been moving sideways in recent weeks.
About Larimar Therapeutics Inc. (LRMR:NASDAQ)
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Top 10 Gainers:
- OmniLit Acquisition Corp. (OLIT:NASDAQ), 100%
- Ebang International Holdings Inc. (EBON:NASDAQ), 35.44%
- Eros STX Global Corporation A (ESGC:NYSE), 30.24%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.28%
- K12 Inc. (LRN:NYSE), 25.04%
- Larimar Therapeutics Inc. (LRMR:NASDAQ), 21.25%
- Groupon, Inc. (GRPN:NASDAQ), 20.02%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 19.81%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 19.59%
- Evolus, Inc. (EOLS:NASDAQ), 17.26%